# | ||||
---|---|---|---|---|
1 | ADVANTAGE ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach | 2015 | 3˙893˙307.00 | 3˙583˙396.00 |
The Institution PROTEINLOGIC LIMITED has been involved also in the following Horizon 2020 projects.